A 28-year-old woman who works as a nurse in a tertiary care hospital in Delhi presents with a 6-week history of persistent cough, malaise, and a 4 kg weight loss. She completed a 6-month course of standard anti-TB therapy 18 months ago for pulmonary TB and was declared cured with sputum conversion. Sputum smear microscopy now shows 1+ acid-fast bacilli. Chest X-ray shows infiltrates in the right upper lobe, different from her previous TB episode. What is the most likely epidemiological classification and what is the primary public health concern in this case?

Explanation

## Relapse TB: Classification, Epidemiology, and Public Health Implications **Key Point:** A patient with a documented history of completed TB treatment and bacteriological cure who develops smear-positive TB again is classified as a **relapse case**. The key distinguishing feature is prior completion of a full standard course of therapy. ### Case Classification Criteria | Feature | New Case | Relapse | Treatment Failure | |---|---|---|---| | **Prior TB treatment** | None or <1 month | Completed full course | Ongoing or interrupted | | **Previous status** | — | Bacteriologically cured | Smear +ve after 5 months | | **Current sputum** | +ve or −ve | +ve (recurrence) | +ve (persistence) | | **Time to recurrence** | — | Variable (months to years) | During or shortly after therapy | | **Drug resistance risk** | Low | Moderate to high | High | **High-Yield:** Relapse cases carry a **25–30% risk of drug-resistant TB** (especially MDR-TB) because: 1. Inadequate initial bacterial clearance despite clinical cure 2. Dormant bacilli with potential acquired resistance mutations 3. Host immune reconstitution failure ### Public Health Concern in This Case **Clinical Pearl:** This patient is a healthcare worker in a tertiary hospital, making her a **high-risk source for occupational TB transmission** to: - Immunocompromised patients (HIV+, post-transplant) - Other healthcare workers - Vulnerable contacts in the hospital setting **Mnemonic:** **RELAPSE = REmission then Loss of Apparent Positive Sputum Effect** ### Management Implications 1. **Drug susceptibility testing (DST):** Mandatory to rule out drug-resistant TB 2. **Treatment regimen:** May require extended therapy or second-line agents if resistance detected 3. **Occupational health:** Temporary removal from patient-care duties pending sputum conversion 4. **Contact tracing:** Household and occupational contacts require screening 5. **Infection control:** Respiratory isolation until smear conversion **Warning:** Do not confuse relapse (recurrence after cure) with treatment failure (persistence during therapy). The timeline and prior treatment completion are critical distinguishing features.